Rongcan Biotech

Shanghai, China · Founded 2020 · Privately Held (backing)

Developer of mRNA-based pharmaceutical products designed for nucleic acid-based therapeutics. Rongcan Biotech is based in Shanghai, China and was founded in 2020. It has raised $13.8 million.

Last price · $/share
—
Implied valuation
—
Total raised
$13.8M
Last round
—

Who backs Rongcan Biotech?

9 investors
InvestorType
Anhui Investment Group HoldingsOther
Guangzhou Yuexiu Industrial Investment Fund ManagementPE / buyout
Hangzhou Huafang Chuangliang Investment ManagementOther
Shaanxi Growth Enterprise Guide FundOther
Win-Win CapitalOther
Jintai Jinhong Investment—
LAV (Lilly Asia Fund)—
Shanghai Biomedical Public Technology—
WuXi AppTec Investment—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Rongcan Biotech investors

Free account
More of Rongcan Biotech with a free account
  • ·Watch Rongcan Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Rongcan Biotech. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View